Stamos Capital Partners, L.P. Johnson & Johnson Transaction History

Stamos Capital Partners, L.P.

$412 Million
Q3 2024

A detailed history of Stamos Capital Partners, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Stamos Capital Partners, L.P. holds 44,900 shares of JNJ stock, worth $6.44 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

44,900

Previous 51,300 12.48%

Holding current value

$6.44 Million

Previous $7.5 Million 2.96%

% of portfolio

1.77%

Previous 1.64%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $931,071 - $1.07 Million	-6,400 Reduced 12.48%	44,900 $7.28 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $343,624 - $375,516	2,380 Added 4.87%	51,300 $7.5 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $99,340 - $104,153	-640 Reduced 1.29%	48,920 $7.74 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $393,120 - $428,976	-2,700 Reduced 5.17%	49,560 $7.77 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $62,300 - $69,792	400 Added 0.77%	52,260 $8.14 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $194,481 - $209,298	-1,260 Reduced 2.37%	51,860 $8.58 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $2.74 Million - $3.27 Million	18,150 Added 51.9%	53,120 $8.23 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $2.73 Million - $3.06 Million	-17,010 Reduced 32.72%	34,970 $6.18 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $1.93 Million - $2.15 Million	11,980 Added 29.95%	51,980 $8.49 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $126,511 - $143,672	-800 Reduced 1.96%	40,000 $7.09 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $803,039 - $891,001	5,150 Added 14.45%	40,800 $6.98 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $326,934 - $350,693	-2,050 Reduced 5.44%	35,650 $5.87 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $1.95 Million - $2.23 Million	14,200 Added 60.43%	37,700 $5.93 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $1.85 Million - $2.23 Million	-14,348 Reduced 37.91%	23,500 $3.31 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $1.53 Million - $2.12 Million	13,768 Added 57.18%	37,848 $4.96 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $181,050 - $207,944	-1,420 Reduced 5.57%	24,080 $3.51 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $1.44 Million - $1.62 Million	11,371 Added 80.48%	25,500 $3.3 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $447,352 - $492,002	-3,411 Reduced 19.45%	14,129 $1.97 Million
Q1 2019 May 10, 2019	SELL	$125.72 - $139.79 $1.82 Million - $2.02 Million	-14,460 Reduced 45.19%	17,540 $2.43 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $3.93 Million - $4.73 Million	32,000 New	32,000 $4.13 Million

Others Institutions Holding JNJ

# of Institutions

4,276

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $375B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Stamos Capital Partners, L.P. with notifications on news.

Account

Stamos Capital Partners, L.P. Johnson & Johnson Transaction History